We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 13th:
Jazz Pharmaceuticals plc (JAZZ - Free Report) : This biopharmaceutical company specializing in neurosciences and oncology has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.1% over the last 60 days.
Glaukos Corporation (GKOS - Free Report) : This ophthalmic medical technology and pharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.3% over the last 60 days.
Spectrum Pharmaceuticals, Inc. : This oncology and hematology focused biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 16.1% over the last 60 days.
Spectrum Pharmaceuticals, Inc. Price and Consensus
Image: Bigstock
Best Momentum Stocks to Buy for July 13th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 13th:
Jazz Pharmaceuticals plc (JAZZ - Free Report) : This biopharmaceutical company specializing in neurosciences and oncology has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.1% over the last 60 days.
Jazz Pharmaceuticals PLC Price and Consensus
Jazz Pharmaceuticals PLC price-consensus-chart | Jazz Pharmaceuticals PLC Quote
Jazz’s shares gained 8% over the last month compared with the S&P 500’s decline of 3.4%. The company possesses a Momentum Score of B.
Jazz Pharmaceuticals PLC Price
Jazz Pharmaceuticals PLC price | Jazz Pharmaceuticals PLC Quote
Glaukos Corporation (GKOS - Free Report) : This ophthalmic medical technology and pharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.3% over the last 60 days.
Glaukos Corporation Price and Consensus
Glaukos Corporation price-consensus-chart | Glaukos Corporation Quote
Glaukos’ shares gained 15.1% over the last month compared with the S&P 500’s decline of 3.4%. The company possesses a Momentum Score of B.
Glaukos Corporation Price
Glaukos Corporation price | Glaukos Corporation Quote
Spectrum Pharmaceuticals, Inc. : This oncology and hematology focused biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 16.1% over the last 60 days.
Spectrum Pharmaceuticals, Inc. Price and Consensus
Spectrum Pharmaceuticals, Inc. price-consensus-chart | Spectrum Pharmaceuticals, Inc. Quote
Spectrum’s shares gained 4.5% over the last month compared with the S&P 500’s decline of 3.4%. The company possesses a Momentum Score of B.
Spectrum Pharmaceuticals, Inc. Price
Spectrum Pharmaceuticals, Inc. price | Spectrum Pharmaceuticals, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.